ChoA Pharmaceutical Co Ltd
034940
Company Profile
Business description
ChoA Pharmaceutical Co Ltd manufactures and sells medicines in South Korea. It offers products for the treatment diarrhea, duodenal ulcer, gastric ulcer, gastritis, cough, cold and others. It also provides nutrition products, health drinks, mixed drinks for children.
Contact
1 floor ACE Techno-Tower
55-7 Mullae-dong 3ga
Youngdungpo-ku
Seoul150-093
KORT: +82 221664000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
275
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks
ASX energy share remains cheap despite strong outlook
Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.
stocks
Moated AI-proof tech play hiding in the ASX 100
ChatGPT and large language models should be a tailwind for this company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,006.40 | 19.00 | -0.21% |
| CAC 40 | 8,166.21 | 61.11 | -0.74% |
| DAX 40 | 24,159.61 | 4.16 | 0.02% |
| Dow JONES (US) | 49,141.86 | 168.46 | -0.34% |
| FTSE 100 | 10,406.50 | 50.51 | -0.48% |
| HKSE | 25,978.07 | 62.87 | 0.24% |
| NASDAQ | 24,604.71 | 166.21 | 0.68% |
| Nikkei 225 | 59,716.18 | 575.95 | 0.97% |
| NZX 50 Index | 12,874.94 | 9.99 | -0.08% |
| S&P 500 | 7,125.65 | 17.25 | 0.24% |
| S&P/ASX 200 | 8,786.50 | 12.10 | -0.14% |
| SSE Composite Index | 4,079.90 | 13.35 | -0.33% |